Maraviroc and Benign salivary gland neoplasm - a phase IV clinical study of FDA data
No or few reports are found.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No or few reports are found.
What is Maraviroc?
Maraviroc has active ingredients of maraviroc. Currently, eHealthMe is studying from 2,579 Maraviroc users.
What is Benign Salivary Gland Neoplasm?
Benign salivary gland neoplasm (salivary gland tumour) is found to be associated with 148 drugs and 63 conditions by eHealthMe. Currently, we are studying 129 people who have Benign salivary gland neoplasm.
Do you take Maraviroc and have Benign salivary gland neoplasm?Check whether Benign salivary gland neoplasm is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Maraviroc side effects by duration, gender and age:
- Maraviroc side effects (2,579 reports)
Benign salivary gland neoplasm treatments and more:
- Benign salivary gland neoplasm (129 reports)
All the drugs that are associated with Benign salivary gland neoplasm:
All the conditions that are associated with Benign salivary gland neoplasm:
How the study uses the data?
The study uses data from the FDA. It is based on maraviroc (the active ingredients of Maraviroc) and Maraviroc (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Eliquis and Communication Disorder - 2 seconds ago
- Humulin N and Oral Infection - 4 seconds ago
- Amlodipine and Tendonitis Exacerbated - 13 seconds ago
- Rabeprazole Sodium and Cough Aggravated - 15 seconds ago
- Ibuprofen and Melaena - 16 seconds ago
- Pradaxa and Intelence drug interaction - 19 seconds ago
- Accolate and Atrial Fibrillation/Flutter - 19 seconds ago
- Nuplazid and Farxiga drug interaction - 28 seconds ago
- Prograf and Therapeutic Response Decreased - 40 seconds ago
- Piroxicam and Atorvastatin Calcium drug interaction - 43 seconds ago